Search

everythinglearnresearchcommunity

for

Search:↓

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

SHBG may be a useful early indicator and treatment target for PCOS.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Significant progress was made in understanding androgen excess disorders, but much is still unknown.

PCOS is a common hormonal disorder in women, treated with lifestyle changes, medication, and patient education.